Revelation Biosciences Inc (REVB)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Aug 17, 2026 | ZYGMONT, CHESTER STANLEY III | Chief Financial Officer | Common Stock | Disposal | 208,073 | $0 |
| Aug 17, 2026 | ZYGMONT, CHESTER STANLEY III | Chief Financial Officer | Common Stock | Acquisition | 208,073 | $0 |
| Aug 17, 2026 | CARVER, JENNIFER | Director | Common Stock | Acquisition | 32,011 | $0 |
| Aug 17, 2026 | CHAWLA, LAKHMIR S | Director | Common Stock | Acquisition | 32,011 | $0 |
| Aug 17, 2026 | ROLKE, JAMES | Director, Chief Executive Officer | Common Stock | Acquisition | 208,076 | $0 |
| Aug 17, 2026 | ROPER, JESS | Director | Common Stock | Acquisition | 32,011 | $0 |
| Apr 30, 2026 | ZYGMONT, CHESTER STANLEY III | Chief Financial Officer | Common Stock | Disposal | 13,285 | $1.10 |
| Apr 30, 2026 | ROLKE, JAMES | Director, Chief Executive Officer | Common Stock | Disposal | 10,115 | $1.13 |
| Feb 4, 2026 | ZYGMONT, CHESTER STANLEY III | Chief Financial Officer | Common Stock | Disposal | 13,100 | $1.65 |
| Feb 3, 2026 | CARVER, JENNIFER | Director | Common Stock | Disposal | 1,661 | $1.87 |
| Feb 3, 2026 | CHAWLA, LAKHMIR S | Director | Common Stock | Disposal | 2,261 | $1.85 |
| Feb 3, 2026 | ROPER, JESS | Director | Common Stock | Disposal | 1,591 | $1.85 |
| Feb 3, 2026 | ROLKE, JAMES | Director, Chief Executive Officer | Common Stock | Disposal | 8,521 | $1.86 |
| Jan 8, 2026 | CARVER, JENNIFER | Director | Common Stock | Acquisition | 41,981 | $0.90 |
| Jan 8, 2026 | ROPER, JESS | Director | Common Stock | Acquisition | 41,981 | $0.90 |
| Jan 8, 2026 | ROLKE, JAMES | Director, Chief Executive Officer | Common Stock | Acquisition | 532,829 | $0.90 |
| Jan 8, 2026 | ZYGMONT, CHESTER STANLEY III | Chief Financial Officer | Common Stock | Acquisition | 78,145 | $0.90 |
| Jan 8, 2026 | CHAWLA, LAKHMIR S | Director | Common Stock | Acquisition | 41,981 | $0.90 |